FA-GDENs carrying survivin siRNA displayed good biocompatibility; they did not alter cell viability of somatic cell (HEK293), Raw 264.7, and cancer cell (KB); and following retro-orbital IV injection they inhibited tumor growth by reducing survivin expression in tumor tissue compared to the scramble group and GDENs without FA [74]. This evidence concerns the gene BIRC5 and cancer.